ArticleFrontiers in nutrition2025
Chemical composition and nutritional properties of
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative Analysis of Extracellular Vesicle-Like Particles From Different ProcessingFood science & nutrition · 2026Article
- Molecular mechanisms and preclinical evidence of natural products in diabetic osteoporosis: a review.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: In this study, WGE was prepared and analyzed for moisture, ash, protein, lipid, mineral, amino acid, total phenolic, and flavonoid content. WGE was analyzed using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS). Furthermore, the effect of WGE on streptozotocin-induced osteoporosis in diabetic rats was explored, along with an in-depth examination of the underlying mechanisms. Results: The results indicated that WGE reduced blood glucose, water, food intake, and body weight and improved Hyperglycemia and organ coefficients. WGE treatment noticeably increased bone mineral density (BMD), repaired bone morphology (BM), restored bone histomorphometric parameters, and ameliorated pathological pancreatic lesions in diabetic rats. It significantly elevated the activity of glutathione (GSH), superoxide dismutase (SOD), and catalase in liver tissues, osteoblast numbers, and the mRNA and protein expression of osteoprotegerin (OPG) and runt-related transcription factor 2 (Runx2). WGE treatment reduced serum inflammatory cytokine levels and the number of osteoclasts and bone marrow adipocytes. Conclusion: The protective effect of WGE against diabetic osteoporosis arises from several mechanisms: lowering blood glucose levels, inhibiting oxidative stress and inflammation, and modulating OPG/receptor activator of nuclear factor-κB ligand (RANKL) expression. Our results indicated that WGE could serve as a theoretical foundation for the treatment of diabetic osteoporosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.